06/02/2024
The unique design of MEndoB makes this an invaluable Precision Antimicrobial for combatting staphylococci, including antimicrobial resistant strains such as methicillin-resistant S. aureus (MRSA). MEndoB could address a wide range of conditions where staphylococcal species have caused an imbalance or disruption to the normal microbial community in or on the human body
Read More01/03/2023
Since its founding in 2005, Micreos has become a world leading developer of endolysin and phage technology, enabling the targeted killing of only unwanted bacteria while protecting the rest of the Microbiome.
Read More18/10/2022
Dr. Matthew Dunne, Dr. Samuel Kilcher and Dr. Anja Keller join us from the Swiss Federal Institute of Technology (ETH Zurich), with theĀ goal of developing synthetic precision antimicrobials for medical indications across infectious and inflammatory diseases.
Read More